Maham Fatima
Sat, January 10, 2026 astatine 1:21 PM CST 2 min read
On December 8, Barclays expert Glen Santangelo initiated sum of Doximity with an Overweight standing and a $63 terms target. While Barclays maintains a mostly Neutral stance connected the broader US healthcare tech and organisation sector, the steadfast is notably bullish connected cause distributors. In contrast, the steadfast holds a much cautious and mixed presumption regarding the dental and healthcare IT sub-sectors.
The company’s strategical absorption connected AI has yielded important idiosyncratic engagement, with AI Scribe users astir tripling betwixt FQ1 2026 and FQ2 2026. Doximity successfully integrated Pathway’s extended aesculapian information sets and AI models into its DoxGPT feature, granting physicians entree to implicit 2,000 aesculapian journals and integrated cause references. Total AI-related Quality Adjusted Users/QAUs roseate 50% quarter-over-quarter, arsenic doctors progressively follow these tools to streamline workflows and objective tasks.
Doximity Inc. (NYSE:DOCS) operates arsenic a integer level for aesculapian professionals successful the US.
While we admit the imaginable of DOCS arsenic an investment, we judge definite AI stocks connection greater upside imaginable and transportation little downside risk. If you’re looking for an highly undervalued AI banal that besides stands to payment importantly from Trump-era tariffs and the onshoring trend, spot our escaped study connected the best short-term AI stock.
READ NEXT: 30 Stocks That Should Double successful 3 Years and 11 Hidden AI Stocks to Buy Right Now.
Disclosure: None. This nonfiction is primitively published at Insider Monkey.

1 day ago
1





English (CA) ·
English (US) ·
Spanish (MX) ·